Form 4: Cidara Therapeutics CEO Sells Shares to Cover Tax Obligations

Cidara Therapeutics CEO Jeffrey Stein disposed of shares to cover tax obligations arising from RSU vesting.

Summary

• On March 11, 2024, Jeffrey Stein, the President and CEO of Cidara Therapeutics, Inc., disposed of 56,692 shares of common stock to cover taxes related to the vesting of Restricted Stock Units (RSUs).
• The shares were sold at a price of $0.69 per share.
• Following the transaction, Stein directly owns 1,153,693 shares of Cidara Therapeutics common stock.
• Stein also indirectly owns 331,602 shares through a trust and 42,009 shares through his son.
• The report also notes that Stein acquired 4,000 shares through the Employee Stock Purchase Plan (ESPP) on November 20, 2023.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates a sale of shares by the CEO to cover tax obligations, which is a common occurrence.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholder sentiment, although it is a common practice for covering tax obligations.

Key Dates